{"id":"https://openalex.org/W91117040","doi":"https://doi.org/10.1096/fasebj.22.1_supplement.706.16","title":"The prevalence of favorable PTEN and MGMT biomarker status in 66 glioblastomas","display_name":"The prevalence of favorable PTEN and MGMT biomarker status in 66 glioblastomas","publication_year":2008,"publication_date":"2008-03-01","ids":{"openalex":"https://openalex.org/W91117040","doi":"https://doi.org/10.1096/fasebj.22.1_supplement.706.16","mag":"91117040"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.22.1_supplement.706.16","doi":"https://doi.org/10.1096/fasebj.22.1_supplement.706.16","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.22.1_supplement.706.16","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062397614","display_name":"Jason De Jesus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason A de Jesus","raw_affiliation_strings":["Dept of Pathology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Pathology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084545137","display_name":"Diana N Lam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diana N Lam","raw_affiliation_strings":["Dept of Pathology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Pathology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059428810","display_name":"Yolanda L Tinajero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yolanda L Tinajero","raw_affiliation_strings":["Dept of Pathology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Pathology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036354940","display_name":"Lorie Kavafyan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lorie Kavafyan","raw_affiliation_strings":["Dept of Pathology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Pathology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069404921","display_name":"JJ H. Zhang","orcid":"https://orcid.org/0000-0003-3077-0770","observed_orcids":["https://orcid.org/0000-0003-3077-0770","https://orcid.org/0000-0003-2177-6062"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haijing Zhang","raw_affiliation_strings":["Dept of Pathology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Pathology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034826914","display_name":"Philippe Taieb","orcid":"https://orcid.org/0000-0003-4287-3371","observed_orcids":["https://orcid.org/0000-0003-4287-3371"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philippe Taieb","raw_affiliation_strings":["Dept of Pathology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Pathology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064128264","display_name":"Victoria C Deguzman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victoria C Deguzman","raw_affiliation_strings":["Dept of Pathology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Pathology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042065032","display_name":"Paul S. Mischel","orcid":"https://orcid.org/0000-0002-4560-2211","observed_orcids":["https://orcid.org/0000-0002-4560-2211"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul S Mischel","raw_affiliation_strings":["Dept of Pathology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Pathology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063511816","display_name":"Timothy Francis Cloughesy","orcid":"https://orcid.org/0000-0002-8656-7483","observed_orcids":["https://orcid.org/0000-0002-8656-7483"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy F Cloughesy","raw_affiliation_strings":["Dept of Neurology UCLA School of Medicine Los Angeles CA","Dept of Neurology, UCLA School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Neurology UCLA School of Medicine Los Angeles CA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Dept of Neurology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016190247","display_name":"William H. Yong","orcid":"https://orcid.org/0000-0002-0879-0209","observed_orcids":["https://orcid.org/0000-0002-0879-0209"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William H Yong","raw_affiliation_strings":["Brain Research Institute Los Angeles CA","Dept of Pathology","Brain Research Institute, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brain Research Institute Los Angeles CA","institution_ids":[]},{"raw_affiliation_string":"Dept of Pathology","institution_ids":[]},{"raw_affiliation_string":"Brain Research Institute, Los Angeles, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00750486,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":1.0},{"id":"https://openalex.org/keywords/pten","display_name":"PTEN","score":0.9670000076293945},{"id":"https://openalex.org/keywords/mgmt","display_name":"MGMT","score":0.9890000224113464},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8659999966621399},{"id":"https://openalex.org/keywords/temozolomide-response","display_name":"temozolomide response","score":0.7789999842643738},{"id":"https://openalex.org/keywords/egfr-kinase-inhibitors","display_name":"EGFR kinase inhibitors","score":0.8970000147819519},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.5849999785423279},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.7490000128746033},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.9922088384628296},{"id":"https://openalex.org/C2779549131","wikidata":"https://www.wikidata.org/wiki/Q83167294","display_name":"Tensin","level":5,"score":0.8158838748931885},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6437084078788757},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.6155433654785156},{"id":"https://openalex.org/C4224716","wikidata":"https://www.wikidata.org/wiki/Q10859258","display_name":"Immunostaining","level":3,"score":0.5596473217010498},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.5274710059165955},{"id":"https://openalex.org/C193270364","wikidata":"https://www.wikidata.org/wiki/Q17141925","display_name":"Tissue microarray","level":3,"score":0.4681195318698883},{"id":"https://openalex.org/C178666793","wikidata":"https://www.wikidata.org/wiki/Q422476","display_name":"Phosphatase","level":3,"score":0.4479425251483917},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4024308919906616},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36844831705093384},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3500337600708008},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.16105705499649048},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.1387517750263214},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.13310006260871887},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06655293703079224},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.22.1_supplement.706.16","doi":"https://doi.org/10.1096/fasebj.22.1_supplement.706.16","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.22.1_supplement.706.16","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5799999833106995}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2352568601","https://openalex.org/W2896764561","https://openalex.org/W2357679775","https://openalex.org/W2186965932","https://openalex.org/W2050559257","https://openalex.org/W2374272643","https://openalex.org/W2046077454","https://openalex.org/W4256467525","https://openalex.org/W2109559424","https://openalex.org/W2355266152"],"abstract_inverted_index":{"Glioblastomas":[0],"are":[1,95,104,186],"genetically":[2],"heterogeneous":[3],"neoplasms":[4],"with":[5,44],"variable":[6],"responses":[7],"to":[8,14,46,70,81,188,206],"therapy.":[9,194],"Biomarkers":[10],"that":[11,55],"predict":[12],"response":[13,45,69],"therapy":[15],"include":[16],"O6\u2010methylguanine\u2010DNA":[17],"methyl":[18],"transferase":[19],"(MGMT)":[20],"and":[21,23,33,62,109,177],"phosphatase":[22,54],"tensin":[24],"homolog":[25],"(PTEN).":[26],"MGMT":[27,37,108,138,165,178],"is":[28,52,119,129,147,204],"a":[29,53,67,86,100,156,163,174,182],"DNA":[30],"repair":[31],"enzyme":[32],"low":[34],"levels":[35],"of":[36,64,85,115,144,152,169,184,193,198],"expression":[38],"in":[39,90,97,140],"tumors":[40,154],"have":[41,155,162,172,189],"been":[42],"associated":[43],"Temazolamide,":[47],"an":[48],"alkylating":[49],"agent.":[50],"PTEN":[51,65,110,124,158,176],"modulates":[56],"signaling":[57],"pathways":[58],"downstream":[59],"from":[60],"EGFR":[61,73],"loss":[63,125],"predicts":[66],"poor":[68],"small":[71],"molecule":[72],"kinase":[74],"inhibitors.":[75],"In":[76],"this":[77],"study,":[78],"we":[79],"attempt":[80],"assess":[82],"the":[83,153,170],"prevalence":[84],"favorable":[87,157,164,175],"biomarker":[88],"status":[89],"66":[91],"glioblastomas.":[92],"The":[93,113],"glioblastomas":[94,171],"sampled":[96],"triplicate":[98],"on":[99],"tissue":[101],"microarray.":[102],"Sections":[103],"then":[105],"assayed":[106],"for":[107],"by":[111],"immunohistochemistry.":[112],"extent":[114],"tumor":[116,145],"cell":[117],"staining":[118],"semi\u2010quantitatively":[120],"scored":[121],"as":[122,132],"percentages.":[123],"greater":[126],"than":[127,142],"25%":[128],"considered":[130,148],"deficient":[131],"previously":[133],"reported.":[134],"By":[135],"published":[136],"criteria,":[137],"immunostaining":[139],"less":[141],"20%":[143],"cells":[146],"favorable.":[149],"72.7%":[150],"(48/66)":[151],"status.":[159,166,179],"37.8%":[160],"(25/66)":[161],"27.3%":[167],"(18/66)":[168],"both":[173],"Therefore,":[180],"only":[181],"minority":[183],"patients":[185],"predicted":[187],"available":[190],"two":[191],"lines":[192],"To":[195],"avoid":[196],"use":[197],"possibly":[199],"ineffective":[200],"therapies,":[201],"more":[202],"work":[203],"needed":[205],"identify":[207],"other":[208],"predictive":[209],"biomarkers.":[210]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}